Torrent Pharmaceuticals Limited has announced the release of the transcript for their conference call with analysts and investors. This call discussed the company's financial results for the quarter and the nine months ended December 31, 2025. The transcript is now available on the company's official website at the following link: https://torrentpharma.com/pdf/investors/Q3-FY25-26_Earnings-Call-Transcript.pdf This disclosure is made in continuation of their previous letter dated February 2, 2026, and in compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
